Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeNominating and Governance CommitteeCompensation CommitteeScience & Technology Committee
Sunil Agarwal, M.D. 
Sunil Agarwal, M.D.
Independent Director


Sunil Agarwal, M.D., joined our board of directors in March 2016. Dr. Agarwal serves as executive vice president and chief medical officer for Ultragenyx Pharmaceutical, where he leads the company's clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology and toxicology. Dr. Agarwal served in various leadership roles at Genentech for more than a decade, including senior vice president and global head of clinical development for opht... 

   Committee Member Chairperson
Mary Cranston Financial Expert
Mary Cranston
Independent Director


Mary Cranston joined MyoKardia as an independent director in April 2016. Ms. Cranston is a retired senior partner of Pillsbury Winthrop Pittman LLP, an international law firm. She was formerly chair and chief executive officer of Pillsbury.

Ms. Cranston currently serves as a director of Visa Inc., The Chemours Company and CSAA Insurance. She is also the chair of the board of the Stanford Children's Hospital and Children's Health Network. She previously served as a member of the boards... 

Chairperson Chairperson   
Tassos Gianakakos 
Tassos Gianakakos
Chief Executive Officer


Tassos Gianakakos joined MyoKardia in October 2013, bringing more than 17 years of senior leadership experience and business development and finance expertise in the biopharmaceutical industry to the company. He joined MyoKardia from MAP Pharmaceuticals (acquired by Allergan in March 2013), where he was most recently senior vice president and chief business officer. In this position, Mr. Gianakakos played an integral role in advancing the company’s two Phase 3 clinical programs and regulatory... 

    
David Meeker 
David Meeker
Independent Director


David Meeker, M.D., is executive vice president and head of Sanofi Genzyme, the specialty care global business unit of Sanofi that focuses on rare diseases, multiple sclerosis, oncology, and immunology. As executive vice president of Sanofi, he served as a member of the executive committee. Dr. Meeker joined Genzyme in 1994 and held positions of increasing responsibility including vice president, medical affairs, chief operating officer and ultimately president and chief executive officer. Pr... 

    Committee Member
Mark Perry Financial Expert
Mark Perry
Independent Director


Mark Perry is a biotech veteran with more than 30 years of industry experience. Mr. Perry has served as an entrepreneur-in-residence at Third Rock Ventures and as president, chief executive officer and director of Aerovance, Inc., a biotechnology company focused on the development of human therapeutics for respiratory and allergic diseases. From 1994 to 2007, Mr. Perry served in several executive roles at Gilead Sciences, Inc., including executive vice president of operations, as well as gene... 

Committee Member   Chairperson  
Kimberly Popovits 
Kimberly Popovits
Independent Director
  Committee Member   
Wendy Yarno 
Wendy Yarno
Independent Director
Committee Member   Committee Member